Abstract:The Fc gamma receptor (FcγR), a member of the immunoglobulin superfamily, binds the IgG Fc segment of antibodies and is mainly expressed on the surface of immune cell. The FcγR binds to the Fc region of an antibody that is attached to target cells, transmitting an activation or inhibition signal to the FcγR expressing cells, resulting in various biological responses and functions. Many therapeutic antibodies are developed based on the engineering of the Fc region to fine-tune the FcγR mediated effects. There are four subtypes of mouse FcγRs, including Fcgr1, Fcgr2b, Fcgr3, and Fcgr4. In contrast, human FcγRs consist of at least seven members, including FCGR1A, FCGR1B, FCGR2A, FCGR2B, FCGR2C, FCGR3A, and FCGR3B. Additionally, the expression pattern of even the orthologous FcγR genes varies between humans and mice. e.g., the distribution of mouse FCGR3 and FCGR2. Therefore, animals harboring the murine FcγRs are not ideal models for the accurate preclinical evaluation of human therapeutic antibodies. To address this problem, we established an FcγRs fully humanized mouse model by injecting an engineered human bacterial artificial chromosome construct carrying all seven human FcγR genes into mouse zygotes. The transgene carriers were mated with another strain in which all mouse FcγR genes were knocked out to establish the colony. Unlike the endogenous mouse FcγR genes expression profiles, the transgenic human FcγR genes regulated under the control of the human control elements retain the human expression pattern. For example, the transgenic human FCGR3A was observed on mouse NK cells and macrophages, whereas the FCGR3B was detected on mouse neutrophils only, which were consistent with their expression patterns in humans. Antibody-dependent cellular cytotoxicity (ADCC) experiment indicated that a human therapeutic antibody could direct NK cells derived from the FcγRs fully-humanized mice to kill target tumor cells. Moreover, a significant anti-tumor effect could also be achieved by an ADCC based human antibody in tumor-bearing FcγRs humanized mice. Taken together, the FcγR gene fully-humanized model established in this study demonstrates a human FcγR expression pattern and functionality, thus providing a valuable tool for accurate preclinical evaluation of human therapeutic antibodies. Citation Format: Mingkun Zhang, Cunxiang Ju, Ying Li, Yunlong Jiang, Weiwei Yu, Shuai Li, Hongyan Sun, Zhiying Li, Jing Zhao, Xiang Gao. Development of an Fc gamma receptor fully-humanized mouse model to support the accurate preclinical study of therapeutic antibodies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 2584.

Antigen-specific Human T-cell Responses and T Cell–dependent Production of Human Antibodies in a Humanized Mouse Model

Abstract 2584: Development of an Fc gamma receptor fully-humanized mouse model to support the accurate preclinical study of therapeutic antibodies

Reconstitution of a Functional Human Immune System in Immunodeficient Mice Through Combined Human Fetal Thymus/liver and CD34+ Cell Transplantation.

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles

T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes

A Novel Humanized Mouse Model with Significant Improvement of Class-Switched, Antigen-Specific Antibody Production

Human Natural Regulatory T Cell Development, Suppressive Function, and Postthymic Maturation in a Humanized Mouse Model

A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses

Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease

Human Lymphohematopoietic Reconstitution and Immune Function in Immunodeficient Mice Receiving Cotransplantation of Human Thymic Tissue and CD34+ Cells

Improved B cell development in humanized NOD -scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3

De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids

1225 NCG-SGM3 Humanized Mice – an Ideal Model for Human Immune Reconstitution of T and Myeloid Cell Lineages

Establishment of a human microbiome- and immune system-reconstituted dual-humanized mouse model

A New Humanized Mouse Model Mimics Humans in Lacking α-Gal Epitopes and Secreting Anti-Gal Antibodies

Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents

TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice

Efficient peripheral construction of functional human regulatory CD4 +CD25 highFoxp3 + T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34 + cells

Distribution and Identification of Immunocytes in Humanized SCID Mouse Model

Improvement of Human Myeloid and Natural Killer Cell Development in Humanized Mice Via Hydrodynamic Injection of Transposon Plasmids Containing Multiple Human Cytokine Genes.

The hu-mice were made by intravenous injection of TCR-engineered HLA-A * 0201 + CD 34 + FLCs into NOD